ARCHIVES

Faulding, NaPro In Agreement For Marketing Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993

Grant, contract Awards Held Up By Impasse On Appropriations

October 14, 1977

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year

May 12, 1978

Porter Softens Proposal To require SBIR Scores To Match R01s

July 26, 1996

Applications Pour In for construction Grants; Three Compete For Mouse Laboratory

June 1, 1990